Ingram Micro to Replace Pacira in S&P SmallCap 600 Amid Viatris Deal
S&P Dow Jones Indices announced on November 11, 2026 that Ingram Micro Holding will replace Pacira BioSciences in the S&P SmallCap 600 before trading opens on November 17, 2026. The replacement comes as S&P 500 constituent Viatris moves toward completing its pending acquisition of Pacira at an aggregate equity value of US$1.65 billion, a deal expected to close soon subject to final closing conditions. Ingram Micro trades on the NYSE under INGM and enters with an Information Technology…